Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

Presentation TCT 2023

Patient Reported Outcomes in TTVI: Are They Meaningful?

Presenter: David Cohen

October 26, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

We Need an RCT, and Here Is How I Would Like to Design It

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

Importance of Patient Reported Outcomes

Presenter: David Cohen

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

There Are Reasons to Be Cautious – Look Beyond the Anatomy!

Presenter: David Cohen

October 23, 2023

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

Presentation TCT 2022

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Presenter: David Cohen

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Advertisement

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

What’s Going to Be Hot at TCT 2025

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Patient Reported Outcomes in TTVI: Are They Meaningful?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

We Need an RCT, and Here Is How I Would Like to Design It

Importance of Patient Reported Outcomes

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

There Are Reasons to Be Cautious – Look Beyond the Anatomy!

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

New Faces, New Formats, New Tech: What to Expect From TCT 2022

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content